Skip to content
Search

Latest Stories

Another Boots pharmacy in York to close in February

Another Boots pharmacy in York to close in February

The retailer’s flagship store in Coney Street also faces demolition due to a major regeneration project

The Boots pharmacy in Clifton, near Clifton Green, has put up a notice to inform the community that the shop will be permanently closed from February 17, and that customers can visit the other branch in Coney Street for collecting prescription.


The sign in the store’s window also listed other nearby Boots stores in Front Street, Acomb, and the store in Monks Cross Shopping Park for availing the service, The Press reported.

Closure of Boots branches across York is part of the retailer’s plans to close 300 stores nationwide over the course of the upcoming year, reducing their total number from 2,200 stores to approximately 1,900.

The store in King’s Square was closed in October as the company continues to consolidate stores in close proximity to each other.

Further, the report indicated the pharmacy chain’s flagship store in Coney Street may be demolished in the future, citing a major regeneration project.

Early this year, the Helmsley Group had submitted their proposals for Coney Street and the riverside. to the City of York Council.

A Boots spokesperson previously told the publication that the lease on their Coney Road store will end this year, but they are committed to retaining their presence in the city centre, and they were in the process of reviewing alternative options.

Last month, Walgreens Boots Alliance (WBA) transferred its £4.8 billion ($6 billion) pension plan to Legal & General, by signing a buy-in deal.

The company said it was the best option to insure all 53,000 members in the Boots Pension Scheme against market uncertainty, improved life expectancies and other risks.

Members of the Pharmacists’ Defence Association (PDA) who have benefits in the Scheme have decided to challenge the removal of the option to retire at 60 without a reduced pension, which followed after the deal.

More For You

RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less